HIGHLIGHTS
- who: Report and colleagues from the Al-Qura University, Department of Medicine, Ibn Sina National College for Medical Studies, Jeddah have published the research: Review began 01/06/2023 Review ended 01/27/2023 Published 01/29/2023 u00a9 Copyright, in the Journal: (JOURNAL) of January/29,/2023
- what: 2023 Khan et_al Cureus 15(1): e34339.
SUMMARY
Captopril is an angiotensin-converting enzyme (ACE) inhibitor, a pharmaceutical medication approved by the Food and Drug Administration (FDA), to treat hypertension and left ventricular dysfunction with or without myocardial infarction. Rare adverse events . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.